About
Small Molecules?
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
12
As Collaborator
0
Total Enrollment
1,418
By Phase
PHASE1/PHASE2: 9PHASE1: 3
By Status
RECRUITING: 4UNKNOWN: 4COMPLETED: 3NOT_YET_RECRUITING: 1
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06973564Lead Sponsor
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
PHASE1/PHASE2Not yet recruiting
294 participants
Started: May 31, 2025 · Completed: Feb 29, 2028
NCT06959615Lead Sponsor
A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration
PHASE1/PHASE2Recruiting
334 participants
Started: Nov 22, 2024 · Completed: Aug 31, 2027
NCT06386146Lead Sponsor
JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
PHASE1/PHASE2Recruiting
144 participants
Started: Jul 24, 2024 · Completed: Jul 31, 2027
NCT05490472Lead Sponsor
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
102 participants
Started: Dec 20, 2022 · Completed: Aug 31, 2026
NCT05174585Lead Sponsor
JAB-BX102 Monotherapy and Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
62 participants
Started: Aug 18, 2022 · Completed: Mar 31, 2026
Locations (1)
Headquarters
Beijing, China
Map
Loading map...